Protalix Biotherapeutics, Inc. (PLX)
2.48
+0.08
(+3.33%)
USD |
NYAM |
Aug 26, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Total Assets (Quarterly) : 110.34M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 110.34M |
| March 31, 2026 | 102.34M |
| December 31, 2025 | 82.35M |
| September 30, 2025 | 82.26M |
| June 30, 2025 | 78.49M |
| March 31, 2025 | 73.89M |
| December 31, 2024 | 73.42M |
| September 30, 2024 | 61.56M |
| June 30, 2024 | 91.54M |
| March 31, 2024 | 89.82M |
| December 31, 2023 | 84.43M |
| September 30, 2023 | 87.57M |
| June 30, 2023 | 88.42M |
| March 31, 2023 | 66.56M |
| December 31, 2022 | 55.79M |
| September 30, 2022 | 56.71M |
| June 30, 2022 | 60.64M |
| March 31, 2022 | 68.39M |
| December 31, 2021 | 73.66M |
| September 30, 2021 | 83.48M |
| June 30, 2021 | 108.20M |
| March 31, 2021 | 102.79M |
| December 31, 2020 | 67.93M |
| September 30, 2020 | 72.31M |
| June 30, 2020 | 71.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 82.88M |
| December 31, 2019 | 45.39M |
| September 30, 2019 | 53.73M |
| June 30, 2019 | 55.24M |
| March 31, 2019 | 61.04M |
| December 31, 2018 | 61.13M |
| September 30, 2018 | 65.75M |
| June 30, 2018 | 51.72M |
| March 31, 2018 | 64.80M |
| December 31, 2017 | 72.21M |
| September 30, 2017 | 61.06M |
| June 30, 2017 | 59.00M |
| March 31, 2017 | 71.85M |
| December 31, 2016 | 82.25M |
| September 30, 2016 | 70.47M |
| June 30, 2016 | 78.86M |
| March 31, 2016 | 87.31M |
| December 31, 2015 | |
| September 30, 2015 | 59.49M |
| June 30, 2015 | 65.95M |
| March 31, 2015 | 72.05M |
| December 31, 2014 | 78.47M |
| September 30, 2014 | 84.80M |
| June 30, 2014 | 96.65M |
| March 31, 2014 | 103.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 527.21M |
| Taysha Gene Therapies, Inc. | 470.43M |
| Humacyte, Inc. | 138.09M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.93M |
| Shareholders Equity (Quarterly) | 71.40M |
| Debt to Equity Ratio | 0.1289 |
| Current Ratio | 2.938 |
| Net Debt Paydown Yield | -0.42% |